Qatar Universal Diabetes Outcomes (QUDOS) Study

TerminatedOBSERVATIONAL
Enrollment

475

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions
Diabetes MellitusType 2 Diabetes Mellitus
Trial Locations (1)

Unknown

Weill Cornell Medicine Qatar, Doha

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hamad Medical Corporation

INDUSTRY

lead

Weill Cornell Medical College in Qatar

OTHER

NCT02660476 - Qatar Universal Diabetes Outcomes (QUDOS) Study | Biotech Hunter | Biotech Hunter